Robert W. Shafer
Utrecht University · 386 works · 25,531 citations · h-index 86
Top works
- Exogenous Reinfection with Multidrug-Resistant Mycobacterium tuberculosis in Patients with Advanced HIV Infection
- Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database
- HIV prevalence, immunosuppression, and drug resistance in patients with tuberculosis in an area endemic for AIDS
- Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update
- Characterization of mutation spectra with ultra-deep pyrosequencing: Application to HIV-1 drug resistance
- Multiple Concurrent Reverse Transcriptase and Protease Mutations and Multidrug Resistance of HIV-1 Isolates from Heavily Treated Patients
- Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection
- Viral Population Estimation Using Pyrosequencing
- HIV-1 Genotypic Resistance Patterns Predict Response to saquinavir–ritonavir Therapy in Patients in Whom Previous Protease Inhibitor Therapy Had Failed
- A Mutation in Human Immunodeficiency Virus Reverse Transcriptase and Decline in CD4 Lymphocyte Numbers in Long-Term Zidovudine Recipients
- Drug Resistance Mutations in HIV-1.
- Web Resources for HIV Type 1 Genotypic-Resistance Test Interpretation
- Extrapulmonary Tuberculosis in Patients with Human Immunodeficiency Virus Infection
- The biological and clinical significance of emerging SARS-CoV-2 variants
- Genotypic Testing for Human Immunodeficiency Virus Type 1 Drug Resistance
- Combination Therapy with Zidovudine and Didanosine Selects for Drug-Resistant Human Immunodeficiency Virus Type 1 Strains with Unique Patterns of pol Gene Mutations
- Tuberculosis in Patients Infected with Human Immunodeficiency Virus: Perspective on the Past Decade
- Comparison of Four-Drug Regimens and Pairs of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection
- A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors.
- Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy